Evaluating women with ovarian cancer for BRCA1 and BRCA2 mutations: missed opportunities (Q37629639)

21 August 2017

Evaluating women with ovarian cancer for BRCA1 and BRCA2 mutations: missed opportunities. (English)

1 reference

21 August 2017

1 reference

Molly S Daniels

5

0 references

Kathleen M. Schmeler

8

object named as

Kathleen M Schmeler

1 reference

21 August 2017

10

Karen H Lu

1 reference

21 August 2017

9

David M Gershenson

1 reference

21 August 2017

Larissa A Meyer

1

1 reference

21 August 2017

Meaghan E Anderson

2

1 reference

21 August 2017

Robin A Lacour

3

1 reference

21 August 2017

Anuj Suri

4

1 reference

21 August 2017

Diana L Urbauer

6

1 reference

21 August 2017

Graciela M Nogueras-Gonzalez

7

1 reference

21 August 2017

language of work or name

English

0 references

publication date

1 May 2010

1 reference

Obstetrics and Gynecology

21 August 2017

1 reference

21 August 2017

115

1 reference

21 August 2017

5

1 reference

21 August 2017

945-952

1 reference

What women with ovarian cancer think and know about genetic testing

21 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5295824

Who should be sent for genetic testing in hereditary colorectal cancer syndromes?

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5295824

Improved survival in BRCA2 carriers with ovarian cancer

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5295824

Factors influencing patients' decisions to decline cancer genetic counseling services

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5295824

Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5295824

Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5295824

Identification of the breast cancer susceptibility gene BRCA2

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5295824

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5295824

ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5295824

BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5295824

Attitudes and interest in genetic testing for breast and ovarian cancer susceptibility in diverse groups of women in western Washington.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5295824

BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5295824

“BRCAness” Syndrome in Ovarian Cancer: A Case-Control Study Describing the Clinical Features and Outcome of Patients With Epithelial Ovarian Cancer Associated WithBRCA1andBRCA2Mutations

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5295824

Society of Gynecologic Oncologists Education Committee Statement on Risk Assessment for Inherited Gynecologic Cancer Predispositions☆

3 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5295824

Women's receptivity to testing for a genetic susceptibility to breast cancer

3 December 2018

1 reference

12 December 2020

Effect of BRCA Mutations on the Length of Survival in Epithelial Ovarian Tumors

1 reference

12 December 2020

Clinicopathologic features of BRCA-linked and sporadic ovarian cancer

1 reference

12 December 2020

Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Anglian Breast Cancer Study Group

1 reference

12 December 2020

The genetic attributable risk of breast and ovarian cancer

1 reference

12 December 2020

Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer

1 reference

12 December 2020

ACOG Practice Bulletin No. 103: Hereditary breast and ovarian cancer syndrome

1 reference

12 December 2020

BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes

1 reference

12 December 2020

Clinical and Pathological Features of Ovarian Cancer in Women with Germ-Line Mutations ofBRCA1

1 reference

12 December 2020

Utilization of BRCA1/2 genetic testing in the clinical setting: report from a single institution

1 reference

12 December 2020

BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer

1 reference

12 December 2020

Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk

1 reference

12 December 2020

Risk models for familial ovarian and breast cancer

1 reference

12 December 2020

The role of financial factors in acceptance of clinical BRCA genetic testing

1 reference

12 December 2020

10.1097/AOG.0B013E3181DA08D7

Identifiers

DOI

1 reference

21 August 2017

1 reference

21 August 2017

1 reference